Cabozantinib in advanced renal cell carcinoma: a METEOR impact on clinical practice

por Grassi, Paolo, Verzoni, Elena, Mennitto, Alessia, Procopio, Giuseppe
Publicado 2016

Immunotherapeutic Targets and Therapy for Renal Cell Carcinoma

por Sepe, Pierangela, Mennitto, Alessia, Corti, Francesca, Procopio, Giuseppe
Publicado 2020

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy

por Grassi, Paolo, Verzoni, Elena, Ratta, Raffaele, Mennitto, Alessia, de Braud, Filippo, Procopio, Giuseppe
Publicado 2016

Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review

por Cattrini, Carlo, Caffo, Orazio, De Giorgi, Ugo, Mennitto, Alessia, Gennari, Alessandra, Olmos, David, Castro, Elena
Publicado 2022

Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?

por Roviello, Giandomenico, Buti, Sebastiano, Cattrini, Carlo, Mennitto, Alessia, Messina, Carlo, Airoldi, Chiara, Vannini, Gianmarco, Bersanelli, Melissa
Publicado 2021

Optimal Sequencing and Predictive Biomarkers in Patients with Advanced Prostate Cancer

por Cattrini, Carlo, España, Rodrigo, Mennitto, Alessia, Bersanelli, Melissa, Castro, Elena, Olmos, David, Lorente, David, Gennari, Alessandra
Publicado 2021

Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis

por Cattrini, Carlo, Messina, Carlo, Airoldi, Chiara, Buti, Sebastiano, Roviello, Giandomenico, Mennitto, Alessia, Caffo, Orazio, Gennari, Alessandra, Bersanelli, Melissa
Publicado 2021

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

por Grassi, Paolo, Verzoni, Elena, Ratta, Raffaele, Porcu, Luca, Prisciandaro, Michele, Mennitto, Alessia, Calareso, Giuseppina, de Braud, Filippo, Procopio, Giuseppe
Publicado 2017

Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer

por Raimondi, Alessandra, Sepe, Pierangela, Zattarin, Emma, Mennitto, Alessia, Stellato, Marco, Claps, Melanie, Guadalupi, Valentina, Verzoni, Elena, de Braud, Filippo, Procopio, Giuseppe
Publicado 2020

Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights

por Biello, Federica, Platini, Francesca, D’Avanzo, Francesca, Cattrini, Carlo, Mennitto, Alessia, Genestroni, Silvia, Martini, Veronica, Marzullo, Paolo, Aimaretti, Gianluca, Gennari, Alessandra
Publicado 2021

Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?

por Mennitto, Alessia, Huber, Veronica, Ratta, Raffaele, Sepe, Pierangela, de Braud, Filippo, Procopio, Giuseppe, Guadalupi, Valentina, Claps, Mélanie, Stellato, Marco, Daveri, Elena, Rivoltini, Licia, Verzoni, Elena
Publicado 2020

Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators

por Stellato, Marco, Procopio, Giuseppe, De Giorgi, Ugo, Maruzzo, Marco, Bimbatti, Davide, Mennitto, Alessia, Sbrana, Andrea, Roviello, Giandomenico, Casadei, Chiara, Sepe, Pierangela, Pignata, Sandro, Santini, Daniele
Publicado 2021

The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer

por Vernieri, Claudio, Mennitto, Alessia, Prisciandaro, Michele, Huber, Veronica, Milano, Monica, Rinaldi, Lucia, Cona, Maria Silvia, Maggi, Claudia, Ferrari, Benvenuto, Manoukian, Siranoush, Mariani, Gabriella, Bianchi, Giulia, Capri, Giuseppe, Rivoltini, Licia, de Braud, Filippo
Publicado 2018

Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients

por Cattrini, Carlo, Manfredi, Marcello, Barboro, Paola, Ghirimoldi, Marco, Mennitto, Alessia, Martini, Veronica, Battioni, Alessio, Le Van, Marco, Gobbato, Simone, Branni, Carmen, Ayed, Rahma Ben, Pinato, David James, Catalano, Fabio, Zanardi, Elisa, Boccardo, Francesco, Gennari, Alessandra
Publicado 2023

IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

por Di Salvatore, Mariantonietta, Pietrantonio, Filippo, Orlandi, Armando, Del Re, Marzia, Berenato, Rosa, Rossi, Ernesto, Caporale, Marta, Guarino, Donatella, Martinetti, Antonia, Basso, Michele, Mennitto, Roberta, Santonocito, Concetta, Mennitto, Alessia, Schinzari, Giovanni, Bossi, Ilaria, Capoluongo, Ettore, Danesi, Romano, de Braud, Filippo, Barone, Carlo
Publicado 2017

The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospect...

por Tommasi, Chiara, Scartabellati, Giulia, Giannarelli, Diana, Giorgi, Ugo De, Brighi, Nicole, Fornarini, Giuseppe, Rebuzzi, Sara Elena, Puglisi, Silvia, Caffo, Orazio, Kinspergher, Stefania, Mennitto, Alessia, Cattrini, Carlo, Santoni, Matteo, Verzoni, Elena, Rametta, Alessandro, Stellato, Marco, Malgeri, Andrea, Roviello, Giandomenico, Brunelli, Matteo, Buti, Sebastiano
Publicado 2023

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study

por Pietrantonio, Filippo, Berenato, Rosa, Maggi, Claudia, Caporale, Marta, Milione, Massimo, Perrone, Federica, Tamborini, Elena, Baratti, Dario, Kusamura, Shigeki, Mariani, Luigi, Niger, Monica, Mennitto, Alessia, Gloghini, Annunziata, Bossi, Ilaria, Settanni, Giulio, Busico, Adele, Bagnoli, Pietro Francesco, Di Bartolomeo, Maria, Deraco, Marcello, de Braud, Filippo
Publicado 2016

The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma

por Buti, Sebastiano, Tommasi, Chiara, Scartabellati, Giulia, De Giorgi, Ugo, Brighi, Nicole, Rebuzzi, Sara Elena, Puglisi, Silvia, Caffo, Orazio, Kinspergher, Stefania, Mennitto, Alessia, Cattrini, Carlo, Santoni, Matteo, Verzoni, Elena, Rametta, Alessandro, Stellato, Marco, Malgeri, Andrea, Roviello, Giandomenico, de Filippo, Massimo, Cortellini, Alessio, Bersanelli, Melissa
Publicado 2022

Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials

por Cremolini, Chiara, Milione, Massimo, Marmorino, Federica, Morano, Federica, Zucchelli, Gemma, Mennitto, Alessia, Prisciandaro, Michele, Lonardi, Sara, Pellegrinelli, Alessio, Rossini, Daniele, Bergamo, Francesca, Aprile, Giuseppe, Urbani, Lucio, Morelli, Luca, Schirripa, Marta, Cardellino, Giovanni Gerardo, Fassan, Matteo, Fontanini, Gabriella, de Braud, Filippo, Mazzaferro, Vincenzo, Falcone, Alfredo, Pietrantonio, Filippo
Publicado 2018

Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgr...

por Stellato, Marco, Buti, Sebastiano, Maruzzo, Marco, Bersanelli, Melissa, Pierantoni, Francesco, De Giorgi, Ugo, Di Napoli, Marilena, Iacovelli, Roberto, Vitale, Maria Giuseppa, Ermacora, Paola, Malgeri, Andrea, Maiorano, Brigida Anna, Prati, Veronica, Mennitto, Alessia, Cavo, Alessia, Santoni, Matteo, Carella, Claudia, Fratino, Lucia, Procopio, Giuseppe, Verzoni, Elena, Santini, Daniele
Publicado 2023